- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Addex Therapeutics Ltd (ADXN)Addex Therapeutics Ltd stock price live, this page displays SIX ADXN stock exchange data. View the ADXN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Addex Therapeutics Ltd real time stock price chart below.
What Is the Addex Therapeutics Ltd Stock Price Today?
The Addex Therapeutics Ltd stock price today is 0.055.
What Is the Stock Symbol for Addex Therapeutics Ltd?
The stock symbol for Addex Therapeutics Ltd is "ADXN."
What Stock Exchange Does Addex Therapeutics Ltd Trade On?
Addex Therapeutics Ltd is listed and trades on the Switzerland stock exchange.
Is Addex Therapeutics Ltd a Good Stock to Buy?
Determining whether Addex Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADXN quote. (ISIN: CH0029850754)
What Is the Addex Therapeutics Ltd Stock Price Today?
The Addex Therapeutics Ltd stock price today is 0.055.
What Is the Stock Symbol for Addex Therapeutics Ltd?
The stock symbol for Addex Therapeutics Ltd is "ADXN."
What Stock Exchange Does Addex Therapeutics Ltd Trade On?
Addex Therapeutics Ltd is listed and trades on the Switzerland stock exchange.
Is Addex Therapeutics Ltd a Good Stock to Buy?
Determining whether Addex Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADXN quote. (ISIN: CH0029850754)
Switzerland
Currency in CHF
0.055
-0.007(-11.86%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.055
0.062
52 wk Range
0.040
0.260
ADXN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0550.062
52 wk Range
0.0400.260
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockADXN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Addex Therapeutics Ltd Company Profile
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant for the treatment of Parkinson’s disease levodopa-induced dyskinesia and dystonia, and post-stroke/TBI recovery; ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM) for the treatment of epilepsy; and GABAB PAM for the treatment of pain, anxiety, overactive bladder, and addiction, as well as substance use disorder. Addex Therapeutics Ltd has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the discovery, development, and commercialization of novel mGlu2 PAM compounds for the treatment of CNS and related diseases; license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases; and The Charcot–Marie–Tooth Association to evaluate the role of GABAB PAM compounds in preclinical models of CMT1A. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.
Compare ADXN to Peers and Sector
Metrics to compare | ADXN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADXNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −4.4x | −0.7x | |
PEG Ratio | 0.00 | −0.02 | 0.00 | |
Price/Book | 0.6x | 2.1x | 2.6x | |
Price / LTM Sales | 10.3x | 6.2x | 3.2x | |
Upside (Analyst Target) | 158.1% | 91.2% | 46.4% | |
Fair Value Upside | Unlock | 7.0% | 6.9% | Unlock |
Analysts' Recommendations
0 Buy
0 Hold
2 Sell
Ratings:
1 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 0.160
(+190.91% Upside)
People Also Watch
FAQ
What Is the Addex Therapeutics Ltd (ADXN) Stock Price Today?
The Addex Therapeutics Ltd stock price today is 0.055
What Stock Exchange Does Addex Therapeutics Ltd Trade On?
Addex Therapeutics Ltd is listed and trades on the Switzerland stock exchange.
What Is the Stock Symbol for Addex Therapeutics Ltd?
The stock symbol for Addex Therapeutics Ltd is "ADXN."
What Is the Addex Therapeutics Ltd Market Cap?
As of today, Addex Therapeutics Ltd market cap is 5.41M.
What is Addex Therapeutics Ltd Earnings Per Share?
The Addex Therapeutics Ltd EPS is 0.057.
What Is the Next Addex Therapeutics Ltd Earnings Date?
Addex Therapeutics Ltd will release its next earnings report on 05 Mar 2025.
From a Technical Analysis Perspective, Is ADXN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.